PH11722A - 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension - Google Patents

1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension

Info

Publication number
PH11722A
PH11722A PH17061A PH17061A PH11722A PH 11722 A PH11722 A PH 11722A PH 17061 A PH17061 A PH 17061A PH 17061 A PH17061 A PH 17061A PH 11722 A PH11722 A PH 11722A
Authority
PH
Philippines
Prior art keywords
teritiary
thietyl
ureas
alkyl
pharmaceutical compositions
Prior art date
Application number
PH17061A
Other languages
English (en)
Inventor
G Berezin
P Aldrich
B Ditimar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of PH11722A publication Critical patent/PH11722A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH17061A 1974-04-17 1975-04-16 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension PH11722A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
PH11722A true PH11722A (en) 1978-05-30

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
PH17061A PH11722A (en) 1974-04-17 1975-04-16 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension

Country Status (21)

Country Link
US (1) US4009847A (OSRAM)
JP (1) JPS50148349A (OSRAM)
AR (1) AR208545A1 (OSRAM)
CA (1) CA1047042A (OSRAM)
CH (1) CH611292A5 (OSRAM)
DD (1) DD117223A5 (OSRAM)
DE (1) DE2516554A1 (OSRAM)
DK (1) DK164175A (OSRAM)
ES (1) ES436648A1 (OSRAM)
FI (1) FI751128A7 (OSRAM)
FR (1) FR2267773B1 (OSRAM)
GB (1) GB1461209A (OSRAM)
HU (1) HU173052B (OSRAM)
IE (1) IE41143B1 (OSRAM)
IL (1) IL47095A (OSRAM)
LU (1) LU72306A1 (OSRAM)
NL (1) NL7504570A (OSRAM)
NO (1) NO144071C (OSRAM)
PH (1) PH11722A (OSRAM)
SE (1) SE417965B (OSRAM)
YU (1) YU96075A (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7351834B1 (en) 1999-01-13 2008-04-01 Bayer Pharmaceuticals Corporation ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP1158985B1 (en) * 1999-01-13 2011-12-28 Bayer HealthCare LLC OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
ES2400070T3 (es) * 2001-12-03 2013-04-05 Bayer Healthcare Llc Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
ES2425739T3 (es) * 2002-02-11 2013-10-17 Bayer Healthcare Llc Sorafenib-tosilato para el tratamiento de enfermedades caracterizadas por angiogénesis anormal
US20040023961A1 (en) * 2002-02-11 2004-02-05 Bayer Corporation Aryl ureas with raf kinase and angiogenisis inhibiting activity
AU2003209119A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
CA2475818C (en) * 2002-02-11 2011-07-19 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
US7557129B2 (en) 2003-02-28 2009-07-07 Bayer Healthcare Llc Cyanopyridine derivatives useful in the treatment of cancer and other disorders
DE602004011340T2 (de) * 2003-05-20 2008-11-06 Bayer Healthcare Llc Diaryl-harnstoffe mit kinasehemmender wirkung
NZ544920A (en) * 2003-07-23 2009-11-27 Bayer Healthcare Llc 4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide and metabolites for the treatment and prevention of diseases and conditions
JP2007535565A (ja) * 2004-04-30 2007-12-06 バイエル ファーマシューティカルス コーポレーション 癌の治療に有用な置換ピラゾリル尿素誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NO144071C (no) 1981-06-17
FI751128A7 (OSRAM) 1975-10-18
AU8013575A (en) 1976-10-21
DD117223A5 (OSRAM) 1976-01-05
CH611292A5 (OSRAM) 1979-05-31
JPS50148349A (OSRAM) 1975-11-27
IE41143L (en) 1975-10-17
HU173052B (hu) 1979-02-28
NL7504570A (nl) 1975-10-21
US4009847A (en) 1977-03-01
FR2267773B1 (OSRAM) 1978-08-18
AR208545A1 (es) 1977-02-15
NO751351L (OSRAM) 1975-10-20
IL47095A (en) 1978-03-10
SE417965B (sv) 1981-04-27
ES436648A1 (es) 1977-08-01
IL47095A0 (en) 1975-06-25
LU72306A1 (OSRAM) 1976-03-17
CA1047042A (en) 1979-01-23
GB1461209A (en) 1977-01-13
YU96075A (en) 1983-04-27
IE41143B1 (en) 1979-10-24
DE2516554A1 (de) 1975-10-30
DK164175A (da) 1975-10-18
FR2267773A1 (OSRAM) 1975-11-14
SE7503523L (sv) 1975-10-20
NO144071B (no) 1981-03-09

Similar Documents

Publication Publication Date Title
PH11722A (en) 1-teritiary alkyl-3-substituted phenyl(or thietyl)ureas,pharmaceutical compositions containing same and method of treating hypertension
PH10476A (en) Hexahydro-dibenzo(b,d)pyran-9-ones,compositions containing them and method of use
ZA757481B (en) New antihypertensive compounds and method of preparing same
IL47625A0 (en) Novel quinazoline derivatives and pharmaceutical compositions containing them
IL46695A (en) Substituted n-(1-benzylpyrrolidinyl-2-alkyl)-benzamides, their preparation and pharmaceutical compositions containing them
IL47269A0 (en) New phenylguanidine derivatives,their preparation and pharmaceutical compositions containing them
PH11250A (en) (-aryl-4)substituted piperidinoalkanol derivatives,composition and method of use thereof
PH14072A (en) Substituted acetamidines,guanidines and isothioureas and pharmaceutical compositions thereof
IL47015A (en) Derivatives of phenthylamino-ketones and phenthylamino-dioxolanes,their preparation and pharmaceutical compositions containing them
IL47149A0 (en) New amino acid derivatives,their preparation and pharmaceutical compositions containing them
IL47404A0 (en) Pyrazolobenzazepines,their manufacture and pharmaceutical compositions containing them
NZ179599A (en) Xanthine derivatives, and pharmaceutical compositions containing such
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
ZA752863B (en) Active derivatives of methylemaine, therapeutic compositions containing the same and processes for preparing the said derivatives and compositions
IL48617A0 (en) 11-desoxy-15-substituted-omega-pentanorprostaglandins and pharmaceutical compositions containing them
IL47761A (en) 9-hydroxy-19,20-bis-nor-prostanic acid and derivatives andpharmaceutical compositions containing them
NZ179530A (en) 9-aminoalk(en)yl-9,10-dihydro9,10-methanoanthracenes and pharmaceutical compositions
GB1487007A (en) Nitrofuran hydrazones processes for their preparation and pharmaceutical compositions
IL48147A (en) Pharmaceutical compositions containing substituted tetrahydrofuro(3-4-b)furan2,4-diones and some novel compounds of this type
PH11869A (en) 1-tertiary alkyl-or l-cycloakyl-3*(substituted cyclohexenyl)ureas,pharmaceutical compositions containing same and method of treatment thereof
IL48527A0 (en) New 7,7-diphenyl-hexahydro-1,4-oxazepines,their manufacture and pharmaceutical compositions containing them
PH12431A (en) 1-aryl-uracil,derivatives,pharmaceutical composition and method of use
PH16403A (en) 1-aryloxy-4-amino-2-butanols,their pharmaceutical compositions and method of use
IL46914A0 (en) Pyridylalkylamidines,processes for their preparation and pharmaceutical compositions containing them
IL47254A0 (en) New dibenzothiepine derivatives,their manufacture and pharmaceutical compositions containing them